Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan 15;58(2):195-199.
doi: 10.2169/internalmedicine.1218-18. Epub 2018 Aug 24.

Rectal Paraganglioma

Affiliations
Review

Rectal Paraganglioma

Tomonori Araki et al. Intern Med. .

Abstract

A 57-year-old woman was admitted with lower abdominal pain and bloody bowel discharge. She was diagnosed with rectal tumor by colonoscopy, and a biopsy was performed. Surgery was performed, resulting in a diagnosis of rectal paraganglioma. Since recurrence was confirmed three years later, reoperation was done, and chemotherapy with cyclophosphamide, vincristine and dacarbazine (CVD) was subsequently carried out for further recurrence. After the administration of up to 15 courses of CVD, we delivered best supportive care due to disease progression. She died a year and a half after starting chemotherapy. We herein report this rare disease with a review of the relevant literature.

Keywords: CVD; cyclophosphamide; dacarbazine; paraganglioma; pheochromocytoma; vincristine.

PubMed Disclaimer

Conflict of interest statement

The authors state that they have no Conflict of Interest (COI).

Figures

Figure 1.
Figure 1.
Colonoscopy revealed an elevated lesion in the rectum that was a non-epithelial, soft tumor that easily bled.
Figure 2.
Figure 2.
It shows macro specimen (A), low-power field (B), and high-power field (C-F). The pathological findings showed a Zellballen pattern (C), pseudorosette formation (D), positivity for vascular invasion, lymph node metastasis and more than 50% of the cells were Ki-67 positive at a 200-fold high-power field. The tumor cells were chromogranin A- (E), tyrosine hydroxylase- (F) and dopamine β-hydroxylase-positive (G) and PNMT-negative (H), findings that were consistent with norepinephrine-producing paraganglioma.

References

    1. Eisenhauer EA, Therasse P, Bogaerts J, et al. . New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45: 228-247, 2009. - PubMed
    1. Huang H, Abraham J, Hung E, et al. . Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients. Cancer 113: 2020-2028, 2008. - PMC - PubMed
    1. Tishler AS. Pheochromocytoma and extra-adrenal paraganglioma: updates. Arch Pathol Lab Med 132: 1272-1284, 2008. - PubMed
    1. Young WF., Jr Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am 29: 159-185, 2000. - PubMed
    1. Amar L, Bertherat J, Baudin E, et al. . Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 23: 8812-8818, 2005. - PubMed

MeSH terms

Supplementary concepts